J&J's Weldon to get $143M in retirement

William C. Weldon, who oversaw Johnson & Johnson ($JNJ) during some of its most troubled years, will receive $143.5 million in retirement and deferred compensation after he relinquishes the CEO position, Bloomberg reports. In the last few years, J&J has had a raft of manufacturing problems at McNeil Consumer Health that led to the closing of a plant and the recall of products such as Tylenol. It has faced recalls and litigation over is hip implant products and a scandal over the marketing of its schizophrenia drug Risperdal. Just this week, reports said the Department of Justice had turned down a $1.3 billion settlement offer from J&J for its Risperdal problems because it wasn't enough. Story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.